Visit our exhibition network
April 9–12, 2024 Munich
November 18–20, 2024 Shanghai
April 15–17, 2024 Mumbai
April 2–4, 2025 Ho Chi Minh City
July 8–10, 2025 Johannesburg
Our next fair
analytica has been the world’s leading trade fair for laboratory technology, analysis and biotechnology for five decades.
April 9–12, 2024
Munich
Selected departments
Selected industries
Most read white papers
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.analytica-world.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
03-May-2006 - Fisher Biosciences has acquired BioImage to expand its offering in high content screening and analysis reagent technologies. BioImage complements Fisher Biosciences' existing Cellomics business. BioImage is a leader in the field of High Content Pathway analysis, providing the life-science market ...
14-Feb-2006 - Sigma-Aldrich announced that it has signed a series of agreements that expands its position in the areas of RNA Interference (RNAi), gene expression and cell based assays. Sigma-Aldrich and Genospectra, developer of products to support systems biology and drug discovery efforts, have signed ...
Novel cytometer design opens door to zero gravity readings
21-Jul-2005 - A research journal article* written by scientists at Wyle Laboratories and NASA's Johnson Space Center, both in Houston, USA and published in Cytometry Part B (Clinical Cytometry), describes how Guava Technologies' novel flow cytometric technology offers the potential for ...
06-Apr-2005 - The National Center for Drug Screening (NCDS) located in Shanghai, China and Cellomics, Inc. announced an addition to their strategic collaboration aimed at expanding the application of High Content Screening (HCS) technologies in China. Affiliated with the Shanghai Institute of Materia Medica, ...
11-Feb-2005 - ITI Life Sciences, which has a minimum of £150 million from the Scottish government to invest in life sciences over ten years, announced the launch of a new £3.7 million R&D programme focused on the development of cell-based, pharmaceutical screening technologies to address a significant ...
01-Nov-2004 - Pharmaceuticals and biotechnology companies are under constant pressure to discover and develop new therapeutics at a lesser cost and within shorter timeframes. However, with investments exceeding USD 500 million and nine out of ten candidates failing to get drug approval, pharmaceuticals and ...
26-Aug-2004 - Boston, Mass and Copenhagen, Demark. PerkinElmer Inc. announced plans to collaborate with BioImage to develop cell-based assays on the PerkinElmer EnVision(tm) HTS multilabel plate reader platform. The commercial terms of the collaboration were not disclosed. Based in Denmark, BioImage is a ...
© 1997-2024 LUMITOS AG, All rights reserved